Zydus gets nod from China’s NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
NE HEALTH BUREAU AHMEDABAD, NOV 11 Zydus Lifesciences Limited on Tuesday announced it has received approval from the National Medical ...
NE HEALTH BUREAU AHMEDABAD, NOV 11 Zydus Lifesciences Limited on Tuesday announced it has received approval from the National Medical ...
Under the terms of this agreement, Synthon will be responsible for the development, manufacturing and supply of the finished product ...
Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTMand DOTAREM®, following the receipt of ...
This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of ...
The acquisition will also mark Zydus’ foray into specialised biotech products for health and nutrition, specifically catering to consumers who ...
The theme of this year’s summit will be ‘Managing Brands – Yesterday, Today and Tomorrow’ AMA has invariably remained an ...
Desidustat, a Zydus innovation, is first-of-its-kind oral treatment in India for anemia associated with Chronic Kidney Disease The drug will ...
NE BUSINESS BUREAU AHMEDABAD, FEB 2 City-based pharmaceutical company Zydus on Wednesday announced that it has started the supplies of ...
NE NEWS SERVICE NEW DELHI, AUG 19 Indigenously developed Zydus Cadila Covid vaccine ZyCoV-D has received approval for Emergency Use ...
NE BUSINESS BUREAU NEW DELHI, JULY 1 Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) ...
Email:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com